Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b
Authors
Keywords
-
Journal
Cancer Cell International
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-24
DOI
10.1186/s12935-020-01424-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis
- (2019) Md. Rezanur Rahman et al. Medicina-Lithuania
- microRNA‐29b inhibits cell growth and promotes sensitivity to oxaliplatin in colon cancer by targeting FOLR1
- (2019) Qiang Fu et al. BIOFACTORS
- miR-29b enhances prostate cancer cell invasion independently of MMP-2 expression
- (2018) Renato F. Ivanovic et al. Cancer Cell International
- Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis
- (2018) Hsi-Hsien Hsu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MiR-29b reverses oxaliplatin-resistance in colorectal cancer by targeting SIRT1
- (2018) Hui Liu et al. Oncotarget
- Deficiency of GATA3-Positive Macrophages Improves Cardiac Function Following Myocardial Infarction or Pressure Overload Hypertrophy
- (2018) Mingjie Yang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?
- (2018) Wim Ceelen EJSO
- The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer
- (2017) Martha L. Slattery et al. GENES CHROMOSOMES & CANCER
- GATA3 expression in triple-negative breast cancers
- (2017) David J Byrne et al. HISTOPATHOLOGY
- GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness
- (2017) M-C Lin et al. ONCOGENE
- ZNF503/Zpo2drives aggressive breast cancer progression by down-regulation of GATA3 expression
- (2017) Payam Shahi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Features of Oxaliplatin Induced Hypersensitivity Reactions and Therapeutic Approaches
- (2016) Nusrat Bano et al. Asian Pacific Journal of Cancer Prevention
- GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression
- (2016) Xingkang Jiang et al. CELLULAR SIGNALLING
- The role of GATA3 in breast carcinomas: a review
- (2016) Rebecca Asch-Kendrick et al. HUMAN PATHOLOGY
- In vivo optical imaging of physiological responses to photostimulation in human photoreceptors
- (2016) Dierck Hillmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Diagnostic Efficacy and Biological Effects of microRNA-29b for Colon Cancer
- (2016) Leping Li et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- GATA3 immunohistochemical expression in invasive urothelial carcinoma
- (2016) Kareem Hosny Mohammed et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals
- (2016) Kun Zhang et al. Oncotarget
- Colorectal cancer development and advances in screening
- (2016) Vanessa Balchen et al. Clinical Interventions in Aging
- A crystal-clear zebrafish for in vivo imaging
- (2016) Paride Antinucci et al. Scientific Reports
- GATA3 in Breast Cancer: Tumor Suppressor or Oncogene?
- (2015) Motoki Takaku et al. GENE EXPRESSION
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- Colorectal cancer
- (2015) Herb Brody NATURE
- MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
- (2015) Yue Teng et al. Oncotarget
- The role of P-glycoprotein in drug resistance in multiple myeloma
- (2014) Joseph Abraham et al. LEUKEMIA & LYMPHOMA
- Negative feedback of miR-29 family TET1 involves in hepatocellular cancer
- (2014) Li Li Lin et al. MEDICAL ONCOLOGY
- The Design of a Quantitative Western Blot Experiment
- (2014) Sean C. Taylor et al. Biomed Research International
- Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system
- (2013) Golam Kibria et al. ARCHIVES OF PHARMACAL RESEARCH
- A novel onco-miR-365 induces cutaneous squamous cell carcinoma
- (2013) Meijuan Zhou et al. CARCINOGENESIS
- miR-29b moulds the tumour microenvironment to repress metastasis
- (2013) Sonia A. Melo et al. NATURE CELL BIOLOGY
- GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression
- (2013) Jonathan Chou et al. NATURE CELL BIOLOGY
- Screening of differentially expressed microRNA in ulcerative colitis related colorectal cancer
- (2013) Yong-Gang Tan et al. Asian Pacific Journal of Tropical Medicine
- Anticancer role of MUC1 aptamer–miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation
- (2012) Furong Dai et al. Targeted Oncology
- Uracils at nucleotide position 9–11 are required for the rapid turnover of miR-29 family
- (2011) Zhuo Zhang et al. NUCLEIC ACIDS RESEARCH
- The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML
- (2010) M Eyholzer et al. BRITISH JOURNAL OF CANCER
- Statistical methods for efficiency adjusted real-time PCR quantification
- (2007) Joshua S. Yuan et al. Biotechnology Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation